LivaNova (LIVN) Common Equity (2014 - 2026)
LivaNova recorded quarterly Common Equity of $1.2 billion in Q1 2026, up 0.94% quarter-over-quarter from $1.2 billion in Q4 2025, and up 17.12% year-over-year from $1.0 billion in Q1 2025.
LivaNova's Common Equity history runs 13 years deep, the most recent figure standing at $1.2 billion for Q1 2026.
- In Q1 2026, Common Equity rose 17.12% year-over-year to $1.2 billion; the TTM figure through Mar 2026 stood at $1.2 billion (up 17.12% YoY), while the FY2025 annual figure was $1.2 billion, down 9.11% from the prior year.
- Common Equity came in at $1.2 billion for Q1 2026 at LivaNova, up from $1.2 billion in the prior quarter.
- In the past five years, Common Equity ranged from a high of $1.3 billion in Q4 2024 to a low of $1.0 billion in Q1 2025.
- A 5-year average of $1.2 billion and a median of $1.2 billion in 2023 frame the typical range for Common Equity.
- Across the five-year window, Common Equity increased 24.63% in 2022 and slipped 15.33% in 2025, its largest moves.
- LivaNova's Common Equity stood at $1.2 billion in 2022, then increased by 5.8% to $1.3 billion in 2023, then rose by 3.34% to $1.3 billion in 2024, then decreased by 9.11% to $1.2 billion in 2025, then rose by 0.94% to $1.2 billion in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $1.2 billion, $1.2 billion, and $1.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 48.99 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.68 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.20 Bn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 1.21 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.21 Bn |
| Dec 31, 2025 | 1.20 Bn |
| Sep 30, 2025 | 1.16 Bn |
| Jun 30, 2025 | 1.12 Bn |
| Mar 31, 2025 | 1.03 Bn |
| Dec 31, 2024 | 1.32 Bn |
| Sep 30, 2024 | 1.31 Bn |
| Jun 30, 2024 | 1.24 Bn |
| Mar 31, 2024 | 1.22 Bn |
| Dec 31, 2023 | 1.28 Bn |
| Sep 30, 2023 | 1.23 Bn |
| Jun 30, 2023 | 1.24 Bn |
| Mar 31, 2023 | 1.23 Bn |
| Dec 31, 2022 | 1.21 Bn |
| Sep 30, 2022 | 1.15 Bn |
| Jun 30, 2022 | 1.28 Bn |
| Mar 31, 2022 | 1.29 Bn |
| Dec 31, 2021 | 1.29 Bn |
| Sep 30, 2021 | 1.30 Bn |
| Jun 30, 2021 | 1.03 Bn |
| Mar 31, 2021 | 1.06 Bn |
| Dec 31, 2020 | 1.11 Bn |
| Sep 30, 2020 | 1.35 Bn |
| Jun 30, 2020 | 1.33 Bn |
| Mar 31, 2020 | 1.39 Bn |
| Dec 31, 2019 | 1.38 Bn |
| Sep 30, 2019 | 1.50 Bn |
| Jun 30, 2019 | 1.48 Bn |
| Mar 31, 2019 | 1.49 Bn |
| Dec 31, 2018 | 1.50 Bn |
| Sep 30, 2018 | 1.78 Bn |
| Jun 30, 2018 | 1.78 Bn |
| Mar 31, 2018 | 1.82 Bn |
| Dec 31, 2017 | 1.82 Bn |
| Sep 30, 2017 | 38.47 Mn |
| Jun 30, 2017 | 870,000.00 |
| Mar 31, 2017 | -56.68 Mn |
| Dec 31, 2016 | 1.71 Bn |
| Sep 30, 2016 | -2.82 Mn |
| Jun 30, 2016 | -24.91 Mn |
| Mar 31, 2016 | -2.49 Mn |
| Dec 31, 2015 | 1.81 Bn |
| Oct 18, 2015 | 278.39 Mn |
| Apr 24, 2015 | 276.57 Mn |
| Oct 24, 2014 | 269.89 Mn |
| Apr 25, 2014 | 259.10 Mn |